Pharmacogenomics, ethnicity, and susceptibility genes

Pharmacogenomics Journal

Volumn 1, Issue 1, 2001, Pages 19-22

  Nebert, D W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HUMAN; PHARMACOGENETICS;

AFRICA; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHARMACOGENETICS;

EID: 0035752835     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500002     Document Type: Article

References (4)

1. Lazarou |, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. lAmMedAssn 1998; 279: 1200-1205.
2. Nebert DW. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? Cin Genet 1999; 56: 247-258.
3. Nebert DW. Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology. Pharmacogenetics 2000; 10: 279-290.
4. Kalow W, Bertilsson L. Interethnic factors affecting drug response. Advanc Drug Res 1994; 23: 1-53.